NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
7.86
+0.41 (5.50%)
Apr 24, 2026, 4:00 PM EDT - Market closed
NeurAxis Market Cap
NeurAxis has a market cap or net worth of $87.93 million as of April 24, 2026. Its market cap has increased by 596.12% in one year.
Market Cap
87.93M
Enterprise Value
83.40M
1-Year Change
596.12%
Ranking
Category
Stock Price
$7.86
Market Cap Chart
Since the IPO on August 9, 2023, NeurAxis's market cap has increased from $18.37M to $87.93M, an increase of 378.64%. That is a compound annual growth rate of 78.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 87.93M | 81.82% |
| Dec 31, 2025 | 48.36M | 194.84% |
| Dec 31, 2024 | 16.40M | 16.15% |
| Dec 29, 2023 | 14.12M | -23.13% |
| Aug 9, 2023 | 18.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inovio Pharmaceuticals | 94.23M |
| Rani Therapeutics Holdings | 93.71M |
| Aldeyra Therapeutics | 93.28M |
| Q32 Bio | 91.00M |
| PolyPid | 88.16M |
| eXoZymes | 87.42M |
| Gossamer Bio | 85.12M |
| Adicet Bio | 84.92M |